Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Guaranteeing Quality Medical care with Federal medical care Benefit Plans.- Boats escort freed whale away from shallow waters off German coast
- The Eastern Bongo, Kenya’s Rare Forest Antelope on the Brink
- Dutch police probe a small blast outside a pro-Israel Christian center
- Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts
- Vote in favor of your #1 sort of juice
- Different Film Classification: What's Your Go-To for Amusement
- 'Something Very Bad Is Going to Happen' is the Duffer Brothers' first project since 'Stranger Things.' It's also 'wildly insane.'
- What Middle East Conflict Could Mean For The World’s Largest Whale Shark Gathering
